MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Investigating Substantia Nigra Damage using Fully Automated Segmentation of Neuromelanin MRI in Early Parkinson’s Disease

    R. Gaurav, R. Valabregue, L. Yahia-Cherif, N. Pyatigorskaya, G. Mangone, E. Biondetti, C. Ewenczyk, M. Hutchison, J.C Corvol, M. Vidailhet, S. Lehéricy (Paris, France)

    Objective: Development of reliable imaging biomarkers of dopaminergic cell neurodegeneration is crucial to facilitate therapeutic drug trials in Parkinson's disease (PD). Neuromelanin-sensitive (NM) MRI techniques…
  • MDS Virtual Congress 2020

    Thalamic nuclei volumes and intrinsic thalamic network in motor subtype in Parkinson’s disease

    J. Park, H.T Kim (Busan, Republic of Korea)

    Objective: The aim of this study is to investigate the alterations of thalamic nuclei volumes and intrinsic thalamic network in patients with de-novo PD according…
  • MDS Virtual Congress 2020

    Impairment of the mesocortical dopamine system in Parkinson’s disease patients with freezing of gait in a multimodal imaging approach

    K. Steidel, M. Ruppert, A. Greuel, I. Palaghia, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers (Marburg, Germany)

    Objective: To investigate the involvement of dopaminergic systems in Parkinson’s disease (PD) patients with freezing of gait (FOG) using a multimodal assessment involving 18 F-DOPA-PET…
  • MDS Virtual Congress 2020

    Bilateral double beta peaks in a PD patient with STN electrodes

    T. Koeglsperger, J. Mehrkens, K. Bötzel (Munich, Germany)

    Objective: We aimed to record LFPs of the subthalamic nucleus (STN) from a PD patient with a new implantable pulse generator (IPG), which is capable…
  • MDS Virtual Congress 2020

    Effects of Long-Term Treatment with Fluvoxamine on Non-Motor Symptoms and Neurogenesis in an Early Post-Natal Stress Rat Model of Parkinson’s Disease

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: To look at the long-term effects of Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), and its neuroprotection potential in a rat model of Parkinson’s…
  • MDS Virtual Congress 2020

    PRO-PARK study: Is there an association between PROfessional occupation and PARKinson´s disease?

    E. Natera-Villalba, V. Ros-Castelló, A. Sánchez-Sánchez, A. Gómez-López, P. Pérez-Torre, S. Fanjul-Arbos, G. García-Ribas, C. Estévez-Fraga, I. Parées -Moreno, J.C Martínez-Castrillo, A. Alonso-Cánovas (Madrid, Spain)

    Objective: To asses if there is an association between professional occupation and Parkinson´s disease (PD). Background: Some personality features including rigidity, less novelty-seeking, and less…
  • MDS Virtual Congress 2020

    Quality of Life in Parkinson´s Disease Patients with Depression and Impulsive-compulsive Behaviors

    D. Santos, T. de Deus, E. Suárez, L. Vela, M. Catalán, M. Álvarez Sauco, I. Gastón, M. Avila, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, M. Seijo, C. Valero, J. González, S. Jesús, Ll. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, I. González Aramburu, V. Nogueira, C. Borrué, B. Solano, S. Escalante, E. Cubo, F. Carrillo, J. Kulisevsky, L. López Manzanares, M. Kurtis, M. Kurtis, P. Mir, P. Martínez Martín (A Coruña, Spain)

    Objective: To analyze quality of life (QoL) in Parkinson´s disease (PD) patients regarding to have depression, impulsive-compulsive behaviors (ICBs), or both. Background: Depression and ICBs are…
  • MDS Virtual Congress 2020

    Long-term effects of air pollution on the risk of Parkinson’s disease

    Y.S Hwang, S.Y Jo, Y.J Kim, K.W Park, S.H Lee, S.J Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the association between air pollution, including fine particulate matter (particles 2.5 mm in diameter, or PM2.5), and the risk of…
  • MDS Virtual Congress 2020

    Psychiatric comorbidities in Young Onset Parkinson’s disease

    A. Patwardhan, P. Pal, N. Kamble, R. Yadav (Bangalore, India)

    Objective: The study aims at exploring psychiatric comorbities;namely;anxiety,depression and impulse control disorders(ICD) and their inter relationship in a large cohort of Young onset PD(YOPD)patients. Background:…
  • MDS Virtual Congress 2020

    Safety and efficacy of istradefylline, an adenosine A2A receptor antagonist, as a function of baseline dyskinesia (BL-dyskinesia) in Parkinson’s disease (PD): A pooled analysis of 4 studies

    L. Elmer, K. Toyama, J. Parno, D. Braccia, R. Ristuccia, A. Mori (Toledo, OH, USA)

    Objective: To evaluate the effect of BL-dyskinesia on the efficacy and safety of istradefylline in 4 randomized, placebo-controlled, double-blind, phase 2b/3 trials. Background: Istradefylline, a…
  • « Previous Page
  • 1
  • …
  • 123
  • 124
  • 125
  • 126
  • 127
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley